visa-vertical-healthtech-anvisa

To align SaMD product discovery with ANVISA constraints, you need a workflow that embeds compliance rules directly into the exploration phase. This ensures pre-registered BR-FUTURE rules are satisfied and produces mandatory classification artifacts like anvisa_classificacao_samd.md.

The best way to integrate LGPD-Saude requirements is to enforce structured compliance outputs during initial product discovery. This generates a Data Protection Impact Assessment artifact, dpia_lgpd_saude.md, to guide your privacy architecture.

You generate compliance artifacts for telemedicine by running a discovery workflow that applies CFM and ANVISA constraints. This enforces mandatory evidentiary lacunas and produces structured governance documents for regulatory alignment.

Yes, this regulatory compliance tool supports digitally-enabled healthcare discovery including digital prescriptions and telemedicine. It integrates CFM constraints into the workflow to ensure compliant product exploration from the outset.

You need to enforce evidentiary lacunas when satisfying BR-FUTURE health rules during healthtech discovery. This identifies mandatory regulatory evidence gaps and generates structured compliance outputs before architecture finalization.